Showing results (141-150 of 289) with videos related to
Sort By:
Pageof 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2014
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysisJack W Hsu, John R Wingard, Brent R Logan, et al.The Lancet. Oncology|February 21, 2012
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective studyKatharina Fleischhauer, Bronwen E Shaw, Theodore Gooley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 monthsMary Eapen, Pablo Rubinstein, Mei-Jie Zhang, et al.Blood|October 31, 2008
Solid cancers after allogeneic hematopoietic cell transplantationJ Douglas Rizzo, Rochelle E Curtis, Gérard Socié, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemiaMukta Arora, Daniel J Weisdorf, Stephen R Spellman, et al.Cancer|January 25, 2017
Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remissionDaniel J Weisdorf, Heather R Millard, Mary M Horowitz, et al.The New England Journal of Medicine|November 27, 2004
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemiaMary J Laughlin, Mary Eapen, Pablo Rubinstein, et al.British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2019
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds ResultsMichael A Pulsipher, Brent R Logan, Deidre M Kiefer, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.Pageof 29